Clarity
Paris
About Clarity
Clarity is a clinical-stage company pioneering a new category of non-pharmacological treatments for neurodegenerative diseases. We develop a neuromodulation device combining immersive technology, AI and biosensors to deliver gamma sensory stimulation. Gamma waves’ sensory stimulation has been shown to significantly slow down Alzheimer's progression, reducing neurodegeneration and cognitive decline. Clarity takes a platform approach by enabling the customization of sensory stimulation protocols based on patient data, improving experience, efficacy and scalability across a wide range of indications. The company was founded by neuroscientists from UC Berkeley, and Oxford along with execs from OURA and Philips, and is supported by leading institutions such as UCSF's Neuroscape.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: clarity-technologies.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Medical, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/clarity-2201210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.